Experienced in Cholangiocarcinoma (Bile Duct Cancer)
Experienced in Cholangiocarcinoma (Bile Duct Cancer)
No. 83 Wenhua Road, 
Shenyang, CN 

Overview

Xingshun Qi practices in Shenyang, China. Qi is rated as an Experienced expert by MediFind in the treatment of Cholangiocarcinoma (Bile Duct Cancer). Their top areas of expertise are Budd-Chiari Syndrome, Mesenteric Venous Thrombosis, Cirrhosis, Splenectomy, and Endoscopy.

Their clinical research consists of co-authoring 416 peer reviewed articles and participating in 3 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 4 articles in the study of Cholangiocarcinoma (Bile Duct Cancer).

Locations

No. 83 Wenhua Road, Shenyang, 110840, China
Other Locations
Xinhua Road, Cangzhou, 061000, China
127 West Chang Le Road, Xi'an, 710032, China
No. 17 West Changle Road, Xi'an, 710032, China

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.


416 Total Publications

Alcohol Consumption Behaviors and Liver Disease: Is There a Safer Drinking Practices?

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Qi's expertise for a condition
ConditionClose
View All 21 Advanced Conditions
View All 96 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile